United States · Venture startup

Who invested in Abeona Therapeutics

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$13Mraised across 3 rounds since 2013, from 3 sources

$750KSeed$3.6MVenture$8.5MVenture
Latest round
Venture, $8.5MJul 2015
Step-upi
2.4×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142015
$750KSeed$3.6MVenture$8.5MVenture
First round
Seed, $750K
Dec 2013
Biggest round
$8.5M
Venture · Jul 2015
Usual gap between rounds
11 months
the median of 2

The rounds

  1. Jul 2015
    Venture$8.5M1 new

    From a historical funding record

  2. Dec 2014
    Venture$3.6M

    No investor was named in the report.

    From a historical funding recordSEC filing: $3.6M sold, first sale Oct 2014

  3. Dec 2013
    Seed$750K

    No investor was named in the report.

    From a historical funding record

Everyone who backed them

George SorosAngel1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Abeona Therapeutics

Who invested in Abeona Therapeutics?

Abeona Therapeutics's investors include George Soros.

How much has Abeona Therapeutics raised?

Abeona Therapeutics has raised $13M across 3 rounds since 2013.

When did Abeona Therapeutics last raise?

Abeona Therapeutics's most recent round was a Venture of $8.5M in Jul 2015.

What was Abeona Therapeutics's biggest round?

Its most recent round, $8.5M in Jul 2015, is also its largest on record.

Who backed Abeona Therapeutics first?

Abeona Therapeutics's first round on record, in Jul 2015, was backed by George Soros.

What stage is Abeona Therapeutics at?

Abeona Therapeutics's latest named round is a Venture, in Jul 2015.

Where is Abeona Therapeutics based?

Abeona Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.